Overview
As a physician scientist in the hematological malignancies and stem cell transplantation division with Sidney Kimmel Comprehensive Cancer Center at the Johns Hopkins, my focus is on the various aspects of cellular therapy in the treatment of hematological malignancies. My primary research focus is to develop strategies to prevent relapse of hematological malignancies following allogeneic stem cell transplantation. Additionally, I serve as the director of the adult CAR T program for hematological malignancies as we grow our CAR T program to help patients with advanced hematological malignancies. My academic interest in this space lies in studying the aspects of toxicity of CAR T cell therapy with an aim to improve long term outcomes in these patients. Among hematological malignancies, myeloproliferative disorders are my area of interest and I work to study newer drugs in early phase of development and also its treatment using allogeneic stem cell transplantation. Patient appointments: 410-955-8893.
Dr. Jain is rated as an Elite provider by MediFind in the treatment of Myeloproliferative Neoplasms (MPN). Her top areas of expertise are Myelofibrosis, Myeloproliferative Neoplasms (MPN), Splenomegaly, Bone Marrow Transplant, and Splenectomy.
Her clinical research consists of co-authoring 132 peer reviewed articles and participating in 1 clinical trial. MediFind looks at clinical research from the past 15 years. In particular, she has co-authored 8 articles in the study of Myeloproliferative Neoplasms (MPN).
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- INSURANCE PLAN
- MEDICARE PDP
- PPO
- HMO
- POS
- PPO
- HMO
- POS
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- OTHER MEDICAID
- STATE MEDICAID
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
401 North Broadway Street, Weinberg BLDG, Weinberg BLDG, Baltimore, MD 21287
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
1 Clinical Trials
Evan Braunstein is a Hematologist Oncology specialist and a Hematologist in Baltimore, Maryland. Dr. Braunstein is rated as a Distinguished provider by MediFind in the treatment of Myeloproliferative Neoplasms (MPN). His top areas of expertise are Myeloproliferative Neoplasms (MPN), Essential Thrombocythemia, Myelofibrosis, Sickle Cell Disease, and Bone Marrow Aspiration. Dr. Braunstein is currently accepting new patients.
Virginia Cancer Specialists, P.C.
Robert Christie is a Hematologist Oncology specialist and a Hematologist in Woodbridge, Virginia. Dr. Christie is rated as a Distinguished provider by MediFind in the treatment of Myeloproliferative Neoplasms (MPN). His top areas of expertise are Lung Cancer, Pleuropulmonary Blastoma, Paget Disease of the Breast, and Multiple Myeloma. Dr. Christie is currently accepting new patients.
Virginia Cancer Specialists, P.C.
Christina Brzezniak is a Hematologist Oncology specialist and a Hematologist in Leesburg, Virginia. Dr. Brzezniak is rated as an Advanced provider by MediFind in the treatment of Myeloproliferative Neoplasms (MPN). Her top areas of expertise are HER-2 Positive Breast Cancer, Myeloproliferative Neoplasms (MPN), Lung Cancer, and Paget Disease of the Breast. Dr. Brzezniak is currently accepting new patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Elite
- MyelofibrosisDr. Jain isElite. Learn about Myelofibrosis.
- Myeloproliferative Neoplasms (MPN)
- Distinguished
- Bone Marrow TransplantDr. Jain isDistinguished. Learn about Bone Marrow Transplant.
- SplenomegalyDr. Jain isDistinguished. Learn about Splenomegaly.
- Advanced
- Acute Lymphoblastic Leukemia (ALL)
- Acute Myeloid Leukemia (AML)Dr. Jain isAdvanced. Learn about Acute Myeloid Leukemia (AML).
- Chronic Graft Versus Host Disease (cGvHD)
- Essential ThrombocythemiaDr. Jain isAdvanced. Learn about Essential Thrombocythemia.
- Felty SyndromeDr. Jain isAdvanced. Learn about Felty Syndrome.
- Graft Versus Host Disease (GvHD)
- Experienced
- Acute Myeloblastic Leukemia with Maturation
- Acute Myeloblastic Leukemia without Maturation
- AgranulocytosisDr. Jain isExperienced. Learn about Agranulocytosis.
- AnemiaDr. Jain isExperienced. Learn about Anemia.
- Aplastic AnemiaDr. Jain isExperienced. Learn about Aplastic Anemia.
- B-Cell LymphomaDr. Jain isExperienced. Learn about B-Cell Lymphoma.